Skip to content

News

News

Sirtex wants medical professionals and patients to understand how our products can help improve clinical outcomes and the quality of life for people with liver cancer. To help achieve this objective, we want to provide medical journalists and health writers with balanced and comprehensive information about our company, our technology and the medical needs we address.

Latest News

Feb 09 2022
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
Read more..

Oct 11 2021
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres® Y-90 resin microspheres in China
Read more..

Jun 08 2021
Sirtex Medical provides donations to Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital in support of the Artzi Lab, as part of Sirtex’s corporate citizenship strategy to support research and innovation
Read more..